Biogen has sued Boston-based biotech Creative Biolabs for allegedly selling copycat versions of its unapproved Alzheimer’s hopeful aducanumab.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,